{"id":"https://openalex.org/W2012195951","doi":"https://doi.org/10.1002/pds.1899","title":"Anxiolytic, hypnotic and sedative medication use in Australia","display_name":"Anxiolytic, hypnotic and sedative medication use in Australia","alternate_titles":[],"publication_year":2010,"publication_date":"2010-02-24","ids":{"openalex":"https://openalex.org/W2012195951","doi":"https://doi.org/10.1002/pds.1899","mag":"2012195951","pmid":"https://pubmed.ncbi.nlm.nih.gov/20073039"},"language":"en","primary_location":{"id":"doi:10.1002/pds.1899","doi":"https://doi.org/10.1002/pds.1899","is_oa":false,"landing_page_url":"https://doi.org/10.1002/pds.1899","pdf_url":null,"source":{"id":"https://openalex.org/S140231191","display_name":"Pharmacoepidemiology and Drug Safety","issn_l":"1053-8569","issn":["1053-8569","1099-1557"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and Drug Safety","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2012195951"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058569306","display_name":"Samantha Hollingworth","orcid":"https://orcid.org/0000-0002-5226-5663","observed_orcids":["https://orcid.org/0000-0002-5226-5663"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]}],"countries":["AU"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Samantha A Hollingworth","raw_affiliation_strings":["School of Population Health, University of Queensland, Herston QLD 4006, Australia. s.hollingworth@uq.edu.au","School of Population Health, University of Queensland, Herston Road, Herston QLD 4006, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Population Health, University of Queensland, Herston QLD 4006, Australia. s.hollingworth@uq.edu.au","institution_ids":["https://openalex.org/I165143802"]},{"raw_affiliation_string":"School of Population Health, University of Queensland, Herston Road, Herston QLD 4006, Australia","institution_ids":["https://openalex.org/I165143802"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001271340","display_name":"Dan J. Siskind","orcid":"https://orcid.org/0000-0002-2072-9216","observed_orcids":["https://orcid.org/0000-0002-2072-9216"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I2801814493","display_name":"Princess Alexandra Hospital","ror":"https://ror.org/04mqb0968","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1302211766","https://openalex.org/I2801244131","https://openalex.org/I2801814493","https://openalex.org/I4210089726"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dan J Siskind","raw_affiliation_strings":["Princess Alexandra Hospital Division of Mental Health, Woolloongabba QLD, Australia","School of Population Health, University of Queensland, Herston QLD, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Princess Alexandra Hospital Division of Mental Health, Woolloongabba QLD, Australia","institution_ids":["https://openalex.org/I2801814493"]},{"raw_affiliation_string":"School of Population Health, University of Queensland, Herston QLD, Australia","institution_ids":["https://openalex.org/I165143802"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5058569306"],"corresponding_institution_ids":["https://openalex.org/I165143802"],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":null,"fwci":6.7077,"has_fulltext":false,"cited_by_count":105,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.96770754,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"19","issue":"3","first_page":"280","last_page":"288"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.5849999785423279,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.5849999785423279,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10272","display_name":"Mental Health Treatment and Access","score":0.20520000159740448,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10316","display_name":"Sleep and related disorders","score":0.030300000682473183,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anxiolytics","display_name":"anxiolytics","score":0.8690000176429749},{"id":"https://openalex.org/keywords/hypnotics","display_name":"hypnotics","score":0.921999990940094},{"id":"https://openalex.org/keywords/sedatives","display_name":"sedatives","score":0.9549999833106995},{"id":"https://openalex.org/keywords/prescribing-trends","display_name":"prescribing trends","score":0.7490000128746033},{"id":"https://openalex.org/keywords/drug-utilisation","display_name":"drug utilisation","score":0.6660000085830688},{"id":"https://openalex.org/keywords/diazepam","display_name":"diazepam","score":0.8450000286102295},{"id":"https://openalex.org/keywords/temazepam","display_name":"temazepam","score":0.8339999914169312},{"id":"https://openalex.org/keywords/zolpidem","display_name":"zolpidem","score":0.9860000014305115},{"id":"https://openalex.org/keywords/alprazolam","display_name":"alprazolam","score":0.8100000023841858},{"id":"https://openalex.org/keywords/oxazepam","display_name":"oxazepam","score":0.9589999914169312},{"id":"https://openalex.org/keywords/nitrazepam","display_name":"nitrazepam","score":0.9869999885559082},{"id":"https://openalex.org/keywords/age-differences-in-drug-use","display_name":"age differences in drug use","score":0.6449999809265137},{"id":"https://openalex.org/keywords/gender-differences-in-drug-use","display_name":"gender differences in drug use","score":0.8759999871253967},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.746999979019165},{"id":"https://openalex.org/keywords/sleep-disturbance","display_name":"sleep disorders","score":0.6060000061988831},{"id":"https://openalex.org/keywords/anxiety-disorders","display_name":"anxiety disorders","score":0.8799999952316284},{"id":"https://openalex.org/keywords/australia","display_name":"Australia","score":0.3059999942779541}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9125363230705261},{"id":"https://openalex.org/C2777602617","wikidata":"https://www.wikidata.org/wiki/Q847705","display_name":"Sedative","level":2,"score":0.86269211769104},{"id":"https://openalex.org/C2777765862","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anxiolytic","level":3,"score":0.7784939408302307},{"id":"https://openalex.org/C2780930544","wikidata":"https://www.wikidata.org/wiki/Q62962","display_name":"Hypnotic","level":2,"score":0.718216061592102},{"id":"https://openalex.org/C2910067630","wikidata":"https://www.wikidata.org/wiki/Q62962","display_name":"Sedative/hypnotic","level":3,"score":0.6781916618347168},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.48308947682380676},{"id":"https://openalex.org/C2909738485","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anti-Anxiety Agents","level":3,"score":0.47317153215408325},{"id":"https://openalex.org/C23276603","wikidata":"https://www.wikidata.org/wiki/Q158230","display_name":"Pharmacoepidemiology","level":3,"score":0.43347764015197754},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.30737122893333435},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.28895437717437744},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.15353813767433167},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.12158766388893127}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000367","descriptor_name":"Age Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001007","descriptor_name":"Anxiety","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001007","descriptor_name":"Anxiety","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D001315","descriptor_name":"Australia","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006993","descriptor_name":"Hypnotics and Sedatives","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010818","descriptor_name":"Practice Patterns, Physicians'","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":true},{"descriptor_ui":"D010818","descriptor_name":"Practice Patterns, Physicians'","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D012737","descriptor_name":"Sex Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012893","descriptor_name":"Sleep Wake Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D012893","descriptor_name":"Sleep Wake Disorders","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016208","descriptor_name":"Databases, Factual","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/pds.1899","doi":"https://doi.org/10.1002/pds.1899","is_oa":false,"landing_page_url":"https://doi.org/10.1002/pds.1899","pdf_url":null,"source":{"id":"https://openalex.org/S140231191","display_name":"Pharmacoepidemiology and Drug Safety","issn_l":"1053-8569","issn":["1053-8569","1099-1557"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and Drug Safety","raw_type":"journal-article"},{"id":"pmid:20073039","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20073039","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacoepidemiology and drug safety","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W158373132","https://openalex.org/W1598981490","https://openalex.org/W1715752662","https://openalex.org/W1881340416","https://openalex.org/W1908193661","https://openalex.org/W1974402406","https://openalex.org/W1989281751","https://openalex.org/W2008252212","https://openalex.org/W2024896027","https://openalex.org/W2034021789","https://openalex.org/W2038637825","https://openalex.org/W2054167035","https://openalex.org/W2071384135","https://openalex.org/W2084577325","https://openalex.org/W2085801833","https://openalex.org/W2091943926","https://openalex.org/W2094233855","https://openalex.org/W2100397981","https://openalex.org/W2101159130","https://openalex.org/W2110207143","https://openalex.org/W2111999572","https://openalex.org/W2112188495","https://openalex.org/W2114135184","https://openalex.org/W2124775321","https://openalex.org/W2127087865","https://openalex.org/W2132954437","https://openalex.org/W2142700192","https://openalex.org/W2143417310","https://openalex.org/W2147677399","https://openalex.org/W2150852249","https://openalex.org/W2160141900","https://openalex.org/W2163397646","https://openalex.org/W2171412462","https://openalex.org/W4236551636","https://openalex.org/W4238340288","https://openalex.org/W4242116142"],"related_works":["https://openalex.org/W1996872821","https://openalex.org/W2067911406","https://openalex.org/W4401499480","https://openalex.org/W2153778295","https://openalex.org/W1582007931","https://openalex.org/W2297486775","https://openalex.org/W2120830237","https://openalex.org/W2099941295","https://openalex.org/W2160141900"],"abstract_inverted_index":{"PURPOSE:":[0],"New":[1],"sedative":[2,26],"drugs":[3,218],"have":[4],"been":[5],"marketed":[6],"in":[7,9,18,30,139,150,161,170,199,210,219],"Australia":[8,43],"the":[10,16,19,31,41,115,127,183,202,227],"last":[11,184],"few":[12],"years.":[13,154,165],"We":[14,39],"examined":[15],"trends":[17],"prescribing":[20,176],"of":[21,60,84,91,159,177,191,205,216,226,231],"subsidised":[22],"anxiolytic,":[23],"hypnotic":[24,109,131],"and":[25,44,63,102,123,207,233],"(AHS)":[27],"medication":[28,105,110],"use":[29,90,136,149,158,190,200,215],"Australian":[32,82],"population":[33,76,86],"from":[34,53,94],"2002":[35,54,101],"to":[36,55,70,96],"2007.":[37,103],"METHODS:":[38],"analysed":[40],"Medicare":[42],"Drug":[45],"Utilisation":[46],"Sub-Committee":[47],"databases":[48],"for":[49],"AHS":[50,92,178],"script":[51],"data":[52],"2007":[56],"by":[57,121,133],"source,":[58],"class":[59],"prescriber,":[61],"gender":[62,197],"5-year":[64],"age":[65],"groups.":[66],"Scripts":[67],"were":[68],"converted":[69],"defined":[71],"daily":[72],"dose":[73],"per":[74,77],"1000":[75],"day":[78],"(DDD/1000":[79],"population/day)":[80],"using":[81],"Bureau":[83],"Statistics":[85],"data.":[87],"RESULTS:":[88],"Overall":[89],"increased":[93,107,180,229],"23.76":[95],"24.11":[97],"DDD/1000":[98],"population/day":[99],"between":[100],"Anxiolytic":[104],"utilisation":[106,111],"as":[108],"decreased.":[112],"Diazepam":[113],"was":[114,126,137,156,168],"most":[116,128],"widely":[117,129],"used":[118,130],"anxiolytic":[119],"followed":[120,132],"alprazolam":[122],"oxazepam.":[124],"Temazepam":[125],"nitrazepam.":[134],"Medication":[135],"concentrated":[138],"those":[140,151,162],"aged":[141,152,163],">":[142],"or":[143],"=":[144],"65":[145],"years":[146],"with":[147],"peak":[148],"85-89":[153],"There":[155,187],"substantial":[157],"anxiolytics":[160],"30-65":[164],"Age-adjusted":[166],"utilization":[167],"higher":[169,203],"females":[171],"than":[172],"males.":[173],"CONCLUSIONS:":[174],"The":[175,196,212],"medications":[179],"slightly":[181],"over":[182],"half":[185],"decade.":[186],"is":[188],"growing":[189],"zolpidem":[192],"on":[193],"private":[194],"prescription.":[195],"differences":[198],"reflect":[201],"prevalence":[204],"anxiety":[206],"sleep":[208],"disorders":[209],"women.":[211],"very":[213],"high":[214],"these":[217],"elderly":[220],"people":[221],"warrants":[222],"further":[223],"exploration":[224],"because":[225],"concomitant":[228],"risks":[230],"mortality":[232],"morbidity.":[234]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2012195951","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":14},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":11},{"year":2013,"cited_by_count":10},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
